Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bukwang Pharm Co Ltd Appoints New CEO


Thursday, 14 Mar 2013 11:02pm EDT 

Bukwang Pharm Co Ltd announced that it has appointed Kim Sang Hun as its new Chief Executive Officer, replacing Lee Seong Gu, effective March 15, 2013. 

Latest Developments for Bukwang Pharm Co Ltd

Company Quote

20000.0
1000.0 +5.26%
30 Sep 2014